These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7590083)
1. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats. Yotsumoto T; Masuda Y; Shudo C; Sugita H; Yamashita T; Tanaka S Gen Pharmacol; 1995 Mar; 26(2):333-7. PubMed ID: 7590083 [TBL] [Abstract][Full Text] [Related]
2. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats. Yokoyama T; Masuda Y; Sakai T; Tanaka S; Tomita K J Cardiovasc Pharmacol; 1992 Jun; 19(6):851-6. PubMed ID: 1376803 [TBL] [Abstract][Full Text] [Related]
3. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats. Shudo C; Masuda Y; Sugita H; Furukawa S; Hayashi K; Hirata H; Tanaka S; Tomita K Gen Pharmacol; 1994 Dec; 25(8):1567-75. PubMed ID: 7721030 [TBL] [Abstract][Full Text] [Related]
4. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury. Kawabata M; Ogawa T; Han WH; Takabatake T Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155 [TBL] [Abstract][Full Text] [Related]
5. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats. Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative. Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414 [TBL] [Abstract][Full Text] [Related]
7. Effects of efonidipine hydrochloride (NZ-105), a new calcium antagonist, against acute renal failure in rats. Shudo C; Masuda Y; Sugita H; Tanaka S; Tomita K Gen Pharmacol; 1994 Nov; 25(7):1451-8. PubMed ID: 7896060 [TBL] [Abstract][Full Text] [Related]
8. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat. Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166 [TBL] [Abstract][Full Text] [Related]
9. Renal effects of the calcium channel blocker aranidipine and its active metabolite in anesthetized dogs and conscious spontaneously hypertensive rats. Ichihara K; Okumura K; Kamei H; Nagasaka M; Kanda A; Kanno T; Miyoshi K; Miyake H J Cardiovasc Pharmacol; 1998 Feb; 31(2):277-85. PubMed ID: 9475270 [TBL] [Abstract][Full Text] [Related]
10. Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats. Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y J Pharm Pharmacol; 1993 Jun; 45(6):525-9. PubMed ID: 8103100 [TBL] [Abstract][Full Text] [Related]
11. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis. Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080 [TBL] [Abstract][Full Text] [Related]